We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intra- and Interobserver Agreement in the Assessment of Human Embryos

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01802801
Recruitment Status : Completed
First Posted : March 1, 2013
Last Update Posted : March 1, 2013
Sponsor:
Information provided by (Responsible Party):
Thomas D'Hooghe, University Hospital, Gasthuisberg

Brief Summary:
The purpose of this study is to determine the intra- and interobserver agreement.

Condition or disease Intervention/treatment
the Focus of This Study is to Measure the Intra- and Interobserver Agreement for the Evaluation of Early Stage Embryos Other: embryo development

Study Type : Observational
Actual Enrollment : 50 participants
Official Title: Intra-and Inter-observer Agreement in the Morphological Assessment of Human Embryos
Study Start Date : December 2007
Primary Completion Date : July 2009
Study Completion Date : August 2009

Group/Cohort Intervention/treatment
1 Other: embryo development
intra- and inter-observator analysis



Primary Outcome Measures :
  1. Evaluation of the intra- and inter-observer variability in the assessement of human embryos
    Variation in observer assessment of embryo characteristics on day 1, 2 and 3 of embryo development. Assessment of these characteristics is standard procedure. Safety and tolerability or efficacy issues are not relevant for this outcome.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 3 Days   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
embryos of IVF/ICSI patients
Criteria

Inclusion Criteria:

  • fertilized embryos

Exclusion Criteria:

  • unfertilized embryos

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01802801


Locations
Belgium
University Hospital Leuven, Catholic University Leuven
Leuven, Belgium
Sponsors and Collaborators
University Hospital, Gasthuisberg

Responsible Party: Thomas D'Hooghe, Prof. Dr., University Hospital, Gasthuisberg
ClinicalTrials.gov Identifier: NCT01802801     History of Changes
Other Study ID Numbers: GP12122007
First Posted: March 1, 2013    Key Record Dates
Last Update Posted: March 1, 2013
Last Verified: February 2013